Prelude TherapeuticsÂ Inc (PRLD) Financials

$5.30

$-0.16 (-2.93%)

As on 08-Sep-2026 16:00EDT

Market cap

$436 Mln

Revenue (TTM)

$22 Mln

P/E Ratio

--

P/B Ratio

3.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	22.42	12.14	7.00	--	--	--
Cost of Revenue	1.23	1.71	1.77	1.17	3.04	2.24
Gross Profit	22.03	10.43	7.00	-1.17	-3.04	-2.24
Operating Expenses	89.43	115.00	146.71	132.28	123.54	113.74
Operating Profit (EBIT)	-67.40	-104.57	-139.71	-132.28	-123.54	-113.74
Other Income	--	--	--	--	--	--
Profit before Tax	-60.49	-99.50	-127.17	-121.83	-115.44	-111.69
Provision for Tax	--	--	--	0.00	-8.10	-0.92
Profit after Tax (Net Income)	-60.49	-99.50	-127.17	-121.83	-107.34	-110.78
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-115.44	-111.69

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	133.73	68.64	131.46	237.09	195.44	285.90
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	17.59	19.68	18.42	18.75	3.36	9.58
Current Liabilities	38.04	52.99	25.64	21.83	21.70	19.20
Total Liabilities	227.41	141.32	175.52	277.67	220.50	305.10

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	34.47	35.62	39.62	42.08	16.12	9.98
Current Assets	154.90	105.69	135.90	235.59	204.38	295.12
Total Assets	227.41	141.32	175.52	277.67	220.50	305.10
Total Debt*	17.65	17.79	18.03	16.89	1.83	1.74
Net Current Assets	116.86	52.70	110.25	213.76	182.68	275.91

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-56.30	-102.89	-107.06	-83.73	-83.53
Cash Flow from Investing Activities	--	53.46	90.19	-34.65	81.69	-263.80
Cash from Financing Activities	--	24.82	-0.12	136.40	0.82	164.90
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.79	-1.58	-1.68	-1.75	-2.24	-2.39
Cash EPS ($)	--	-1.55	-1.65	-1.73	-2.21	-2.37
Adjusted Book Value ($)	--	1.09	1.73	3.41	4.08	6.17
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.89	-1.36	-1.54	-1.75	-1.80
Free Cash Flow per Share ($)	--	-0.90	-1.37	-1.59	-1.81	-1.85

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-84.35	-63.04	-54.00	-44.27	-44.33
ROE (%)	-59.78	-99.45	-69.01	-56.33	-44.60	-44.48
ROA (%)	-33.31	-62.81	-56.12	-48.91	-40.84	-41.91
EBIT Margin (%)	-269.75	-819.59	-1,816.76	--	--	--
Net Margin (%)	-269.75	-819.59	-1,816.76	--	--	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	220.34	0.73	--	--	--	--
EBIT Growth (%)	51.34	21.76	-4.38	1.38	-8.62	-93.55
Net Profit Growth (%)	51.34	21.76	-4.38	-13.51	3.11	-94.59
EPS Growth (%)	51.88	0.06	0.04	0.22	0.06	-0.60
Book Value Growth (%)	36.20	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.83	-0.76	-2.44	-2.70	-5.21
Price / Book Value	3.24	2.66	0.74	1.25	1.48	2.02
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.54	-0.99	0.15	-0.67	-0.73	-2.55
Close Price ($)	5.33	2.90	1.28	4.27	6.04	12.45
High Price ($)	5.68	4.22	6.80	8.57	13.40	95.38
Low Price ($)	0.75	0.61	0.80	1.66	3.87	10.96
Market Cap ($ Cr)	435.73	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.26	0.14	0.07	0.01	0.01
Short term debt to equity ratio	0.02	0.04	0.02	0.01	0.01	0.01
Current Ratio	4.07	1.99	5.30	10.79	9.42	15.37
Quick Ratio	4.07	--	--	--	--	--
Interest Coverage	--	--	--	--	-93.31	-55.73

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.12	0.08	0.03	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	1,250.41	1,268.89	1,774.23	877.52	957.50
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.